Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt

Southern Medical Journal

Volumn 93, Issue 3, 2000, Pages 305-309

  Schiano, Thomas D ^a,b   Black, Martin ^a   Hills, Carver ^a   Ter, Han ^a   Bellary, Somashekhar ^a   Miller, Larry S ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; FUROSEMIDE; GLOBULIN; SPIRONOLACTONE;

ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; ONCOTIC PRESSURE; PARACENTESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME;

EID: 0034064130     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200003000-00011     Document Type: Article

References (27)

1. Dudley FJ: Pathophysiology of ascites formation. Gastroenterol Clin North Am 1992; 21:215-235
2. Arroyo J, Gines P, Planas R: Treatment of ascites in cirrhosis. Gastroenterol Clin North Am 1992; 21:237-256
3. Gines P, Arroyo V, Vargas V, et al: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325;829-836
4. Inturri P, Graziotto A, Rossaro L: Treatment of ascites: old and new remedies. Dig Dis 1996; 14:145-156
5. Standley MM, Ochi S, Kee KK: Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989; 321:1632-1638
6. Wong F, Blendis L: Peritoneovenous shunting in cirrhosis: its role in the management of refractory ascites in the 1990s. Am J Gastroenterol 1995; 90:2086-2089
7. Forrest EH, Stanley AJ, Redhead DN: Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites. Aliment Pharm Ther 1996; 10:801-806
8. Arroyo V, Gines P: TIPS and refractory ascites, lessons from the recent history of ascites therapy. J Hepatol 1996; 25:221-223
9. Ochs A, Rossle M, Haag K: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:1192-1197
10. Shiffman ML, Jeffers K, Hoofnagle JH, et al: The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Disease Advisory Board. Hepatology 1995; 22:1591-1597
11. Kamath PS, McKusick MA: Transvenous intrahepatic portosystemic shunts. Gastroenterology 1996; 111:1700-1705
12. Ferral H, Bjarnason H, Wegryn A, et al: Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189:795-801
13. Wong F, Sniderman K, Kiu, et al: The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997; 112:899-907
14. Hoefs JC: Globulin correction of the albumin gradient: correlation with measured serum to ascites colloid osmotic pressure gradients. Hepatology 1992; 16:396-403
15. Crecelius SA, Soulen MC: Transjugular intrahepatic portosystemic shunts for portal hypertension. Gastroenterol Clin North Am 1995; 24:201-219
16. Conn HO: Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology 1993; 17:148-158
17. Zemel G, Katzen BT, Becker GJ, et al: Percutaneous transjugular portosystemic shunt. JAMA 1991; 266:390-393
18. Dumont AE, Witte MH: Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis. Lymphology 1975; 8:111-113
19. Brooks DP, Share L, Crofton JT: Central adrenergic control of vasopressin release. Neuroendocrinology 1986; 42:416-420
20. Witte CL, Witte MH, Dupont AE, et al: Lymph protein in hepatic cirrhosis and experimental hepatic and portal venous hypertension. Ann Surg 1968; 168:567-577
21. Henriksen JH, Stage JG, Schlicting P, et al: Intraperitoneal pressure, ascitic fluid and splanchnic vascular pressure and their role in prevention and formation of ascites. Scand J Clin Lab Invest 1980; 40:493-502
22. Schaffner FA, Popper H: Capillarization of hepatic sinusoids in man. Gastroenterology 1963; 44:239-242
23. Hoefs JC: Serum protein concentration and portal pressure determine the ascites fluid protein concentration in patients with chronic liver disease. J Lab Clin Med 1983; 102:260-275
24. Cherrick GR, Kerr DNS, Read AE, et al: Colloid osmotic pressure and hydrostatic pressure relationships in the formation of ascites in hepatic cirrhosis. Clin Sci 1960; 19:361-375
25. Witte CL, Witte MH, Cole WR, et al: Dual origin of ascites in hepatic cirrhosis. Surg Gynecol Obstet 1959; 129:1027-1033
26. Griges B, Kunkel HG: Osmotic pressure measurements of serum and ascitic fluid in patients with cirrhosis of the liver. J Clin Invest 1954; 33:257-263
27. Witte CL, Witte MH, Kutner K, et al: Colloid osmotic pressure in hepatic cirrhosis and experimental ascites. Surg Gynecol Obstet 1971; 131:65-71